Publications by authors named "Barbara Ferstl"

Claim this Profile
C
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Andreas Mackensen, John B A G Haanen, Christian Koenecke, Winfried Alsdorf, Eva Wagner-Drouet, Barbara Ferstl

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of Skin Involvement.
Thomas Breakell, Heidi Waibel, Stefan Schliep, Barbara Ferstl, Michael Erdmann

Curr Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.
Nora Liebers, Tobias Roider, Jan-Paul Bohn, Isabella Haberbosch, Andreas Pircher, Barbara Ferstl

Leukemia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial.
Marc S Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Barbara Ferstl

Lancet Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
Ellen Harrer, Michael Bäuerle, Barbara Ferstl, Paul Chaplin, Barbara Petzold

Antivir Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis